More than a year after its emergency authorization, FDA fully approves Pfizer's Covid pill Paxlovid for adults

Zachary Brennan

Senior Editor

More than 510 days since first earning an emergency use authorization, Pfizer’s life-saving Covid-19 pill Paxlovid (nirmatrelvir and ritonavir) finally

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

More than a year after its emergency authorization, FDA fully approves Pfizer's Covid pill Paxlovid for adults

Zachary Brennan

Senior Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

China startup injects CRISPR therapy into the brain for the first time

Trodelvy and Keytruda combo succeeds in Phase 3 breast cancer study

FDA plans to ban pharma employees from serving on adcomms. The impact will be limited

Roivant brings rare disease program closer as Immunovant CEO retires

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

More than a year af­ter its emer­gency au­tho­riza­tion, FDA ful­ly ap­proves Pfiz­er's Covid pill Paxlovid for adults

Senior Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

More than a year after its emergency authorization, FDA fully approves Pfizer's Covid pill Paxlovid for adults